Challenges in Cardiac and Pulmonary Sarcoidosis: JACC State-of-the-Art Review

MG Trivieri, P Spagnolo, D Birnie, P Liu… - Journal of the American …, 2020 - jacc.org
Sarcoidosis is a complex disease with heterogeneous clinical presentations that can affect
virtually any organ. Although the lung is typically the most common organ involved …

PET imaging in cardiac sarcoidosis: a narrative review with focus on novel PET tracers

P Saric, KA Young, M Rodriguez-Porcel… - Pharmaceuticals, 2021 - mdpi.com
Sarcoidosis is a multi-system inflammatory disease characterized by the development of
inflammation and noncaseating granulomas that can involve nearly every organ system …

Long-term adverse cardiac outcomes in patients with sarcoidosis

A Yafasova, EL Fosbøl, M Schou, F Gustafsson… - Journal of the American …, 2020 - jacc.org
Background It is estimated that 5% of patients with sarcoidosis have clinically manifest
cardiac involvement, although autopsy and imaging studies suggest a significantly higher …

Multidisciplinary approach and long-term follow-up in a series of 640 consecutive patients with sarcoidosis: Cohort study of a 40-year clinical experience at a tertiary …

J Mañá, M Rubio-Rivas, N Villalba, J Marcoval… - Medicine, 2017 - journals.lww.com
Cohort studies of large series of patients with sarcoidosis over a long period of time are
scarce. The aim of this study is to report a 40-year clinical experience of a large series of …

Sarcoidosis-associated pulmonary hypertension: pathophysiology, diagnosis, and treatment

HT Duong, CA Bonham - Clinical pulmonary medicine, 2018 - journals.lww.com
Clinicians in pulmonary medicine frequently confront the challenge of screening, diagnosis,
and management of pulmonary hypertension (PH) in sarcoidosis patients who present with …

Cardiac resynchronization therapy response in cardiac sarcoidosis

SA Shabtaie, O Sehrawat, JZ Lee… - Journal of …, 2022 - Wiley Online Library
Introduction Cardiac sarcoidosis (CS) is a nonischemic cardiomyopathy (NICM)
characterized by infiltration of noncaseating granulomas involving the heart with highly …

Epidemiology, pathogenesis, and clinical approach in group 5 pulmonary hypertension

M Al-Qadi, B LeVarge, HJ Ford - Frontiers in Medicine, 2021 - frontiersin.org
Pulmonary hypertension (PH) is recognized to be associated with a number of comorbid
conditions. Based on these associations, PH is classified into 5 groups, considering …

Cardiac Sarcoidosis—Diagnostic and Therapeutic Challenges

D Korthals, M Bietenbeck, H Könemann… - Journal of Clinical …, 2024 - mdpi.com
Sarcoidosis is a multisystem disorder of unknown etiology. The leading hypothesis involves
an antigen-triggered dysregulated T-cell-driven immunologic response leading to non …

Sarcoidosis-associated pulmonary hypertension

MP Huitema, H Mathijssen, JJ Mager… - … in Respiratory and …, 2020 - thieme-connect.com
Pulmonary hypertension (PH) is a well-known complication of sarcoidosis, defined by a
mean pulmonary artery pressure of≥ 25 mm Hg. Since both PH and sarcoidosis are rare …

Case 4-2025: A 41-Year-Old Man with Syncope, Ankle Swelling, and Abnormal Chest Imaging

D Restrepo, S Sultana, S Divakaran… - New England Journal …, 2025 - Mass Medical Soc
A Man with Syncope, Ankle Swelling, and Abnormal Chest Imaging A 41-year-old man was
evaluated for swelling in the ankles and syncope. CT of the chest showed bilateral …